Researchers identify high-IgA MASLD subtype linked to liver-related events

Дата публикации: 09-10-2026 18:20:20

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common liver condition that can follow very different paths among patients. Although fibrosis is a key indicator, some patients without advanced fibrosis can still develop serious liver-related events. This variation led researchers to investigate whether distinct clinical subtypes of MASLD could reveal additional clues about disease progression and risk.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Serum C7 levels predict liver-related events in metabolic fatty liver disease, study finds	0	9.85	08-10-2026
2	Protein discovery reveals potential treatment target for common fatty liver disease	0	9.8	19-10-2026
3	Link between liver fibrosis in MASLD, ASCVD varies by glycemic status	0	6.8	01-08-2026
4	Imaging-based modalities compared for identifying at-risk MASH	0	18.34	16-10-2026
5	GLP-1 treatment linked to lower risk of hospitalization and death in older adults with fatty liver disease	0	6.87	13-10-2026
6	Steatotic liver disease risk scores compared for predicting cirrhosis	0	10.41	25-09-2026
7	Mayo Clinic discovers rare gene mutation that causes fatty liver disease	0	7.1	07-03-2026
8	LAL-D, la malattia rara che si nasconde tra fegato grasso e colesterolo alto	0	10.34	19-10-2026
9	Jusqu'à un adulte sur trois est touché par la MASLD	0	5	03-07-2026
10	Recommendations developed for preventive care in cirrhosis	0	7.97	16-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.32. Источник: medicalxpress.com.